Company Filing History:
Years Active: 2024
Title: Kirthana Prabhakar: Innovator in Antibody Development
Introduction
Kirthana Prabhakar is a notable inventor based in Thousand Oaks, California. She has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. Her work is aimed at addressing medical disorders characterized by the expression of CD22.
Latest Patents
Kirthana holds a patent for "Multispecific heavy chain antibodies binding to CD22 and CD3." This patent discloses multispecific, human heavy chain antibodies, known as UniAbs™, that bind to CD22 and CD3. The patent also includes methods for making these antibodies, as well as compositions, including pharmaceutical formulations, that utilize these antibodies for therapeutic purposes.
Career Highlights
Kirthana is currently employed at Teneobio, Inc., where she continues to advance her research in antibody technology. Her innovative work has the potential to lead to new treatments for various disorders, enhancing the quality of life for many patients.
Collaborations
Some of her notable coworkers include Nathan D. Trinklein and Udaya Rangaswamy, who contribute to the collaborative environment at Teneobio, Inc. Their combined expertise fosters innovation and progress in the field of biotechnology.
Conclusion
Kirthana Prabhakar is a pioneering inventor whose work in multispecific antibodies is paving the way for new therapeutic options. Her contributions to the field are invaluable and highlight the importance of innovation in biotechnology.